FNY Managed Accounts’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-265	Closed	-$9K	–	297
2017 Q1	$9K	Buy	+265	New	+$9K	0.03%	515
2016 Q4	–	Sell	-150	Closed	-$2.08K	–	104
2016 Q3	$2.08K	Sell	150 -199,850	-100%	-$2.77M	﹤0.01%	300
2016 Q2	$1.98M	Buy	+200,000	New	+$1.98M	1.81%	12